Abstract
Although autoimmune syndromes such as systemic lupus erythematosus and dermatomyositis have been previously reported in association with statin use, vasculitis has not been well described. We present a patient with an antineutrophil cytoplasmic antibody-positive, predominantly cutaneous vasculitis, the temporal course of which was associated with simvastatin/ezetimibe use. The patient's serologic findings were consistent with drug-induced disease, with high titer antimyeloperoxidase, in addition to antinuclear and anti-Ro (SSA) antibodies. The patient demonstrated complete resolution of symptoms simply by withdrawing the drug.
MeSH terms
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / chemically induced*
-
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / immunology
-
Antibodies, Antineutrophil Cytoplasmic / blood
-
Anticholesteremic Agents / adverse effects*
-
Autoimmunity / drug effects*
-
Azetidines / adverse effects*
-
Biomarkers / blood
-
Drug Combinations
-
Ezetimibe, Simvastatin Drug Combination
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Male
-
Middle Aged
-
Peroxidase / immunology
-
Ribonucleoproteins / immunology
-
Simvastatin / adverse effects*
Substances
-
Antibodies, Antineutrophil Cytoplasmic
-
Anticholesteremic Agents
-
Azetidines
-
Biomarkers
-
Drug Combinations
-
Ezetimibe, Simvastatin Drug Combination
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Ribonucleoproteins
-
SS-A antigen
-
Simvastatin
-
Peroxidase